Беларусь - русский - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

stockert gmbh, ГЕРМАНИЯ -

Беларусь - русский - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

stockert gmbh, ГЕРМАНИЯ -

Беларусь - русский - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

stockert gmbh, ГЕРМАНИЯ -

Беларусь - русский - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

biosense webster inc., СОЕДИНЕННЫЕ ШТАТЫ АМЕРИКИ -

Беларусь - русский - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

stockert gmbh, ГЕРМАНИЯ -

Израиль - русский - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 5 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

Израиль - русский - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

Израиль - русский - Ministry of Health

dexcel pharma technologies ltd - losartan potassium 50 mg - tablets - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric

Израиль - русский - Ministry of Health

teva pharmaceutical indust.ltd - letrozole 2.5 mg - tablets - letrozole - letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Израиль - русский - Ministry of Health

abic marketing ltd - risedronic acid as sodium 35 mg - tablets - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.